Rikky receives ARPA-H Award

Rikky Muller, associate professor of electrical engineering and computer sciences, is part of a team led by Carnegie Mellon University that will create implantable bioelectronic devices to address obesity and diabetes through a six-year project called RX On-site Generation Using Electronics (ROGUE). ROGUE will precisely stimulate cells within a device to produce drugs to decrease a person’s appetite and cause weight loss — while eliminating the need for periodic injections.

The bioelectronic devices will interface with a secure software platform or app, allowing users to track their condition directly, and will be programmed to deliver therapeutic molecules to the patient on demand for an extended period. This real-time drug delivery and disease tracking system is part of ARPA-H’s Resilient Extended Automatic Cell Therapies (REACT) program.